These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 11085712)

  • 1. Trypsinogen activation peptide in acute pancreatitis.
    Frossard JL
    Lancet; 2000 Aug; 356(9231):766-7. PubMed ID: 11085712
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum and urine concentrations of trypsinogen-activation peptide as markers for acute pancreatitis in cats.
    Allen HS; Steiner J; Broussard J; Mansfield C; Williams DA; Jones B
    Can J Vet Res; 2006 Oct; 70(4):313-6. PubMed ID: 17042387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary trypsinogen activation peptide (TAP)].
    Naruse S
    Nihon Rinsho; 2004 Nov; 62 Suppl 11():131-2. PubMed ID: 15628355
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study.
    Khan Z; Vlodov J; Horovitz J; Jose RM; Iswara K; Smotkin J; Brown A; Tenner S
    Am J Gastroenterol; 2002 Aug; 97(8):1973-7. PubMed ID: 12190163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis.
    Johnson CD; Lempinen M; Imrie CW; Puolakkainen P; Kemppainen E; Carter R; McKay C
    Br J Surg; 2004 Aug; 91(8):1027-33. PubMed ID: 15286966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the predictors of post-ERCP pancreatitis, and how useful are they?
    Sultan S; Baillie J
    JOP; 2002 Nov; 3(6):188-94. PubMed ID: 12432185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary trypsinogen activation peptides (TAP) are not increased in mild ERCP-induced pancreatitis.
    Banks PA; Carr-Locke DL; Slivka A; Van Dam J; Lichtenstein DR; Hughes M
    Pancreas; 1996 Apr; 12(3):294-7. PubMed ID: 8830337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early prediction of severe acute pancreatitis by urinary trypsinogen activation peptide.
    Liu ZS; Jiang CQ; Qian Q; Sun Q; Fan LF; Ai ZL
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):285-9. PubMed ID: 14612286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAPAP in acute pancreatitis: just another marker or real progress?
    Büchler MW; Uhl W; Andrén-Sandberg A
    Gut; 1998 Jan; 42(1):8-9. PubMed ID: 9505874
    [No Abstract]   [Full Text] [Related]  

  • 10. Assay of trypsinogen activation in the cat experimental model of acute pancreatitis.
    Karanjia ND; Widdison AL; Jehanli A; Hermon-Taylor J; Reber HA
    Pancreas; 1993 Mar; 8(2):189-95. PubMed ID: 8460094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of immunoreactive trypsinogen activation peptide in urine in acute pancreatitis.
    Petersson U; Borgström A
    JOP; 2006 May; 7(3):274-82. PubMed ID: 16685108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biochemical markers in assessment of severity and prognosis of acute pancreatitis].
    Petricusić L; Banić M; Cabrijan Z; Urek-Crncević M; Hulak-Karlak V; Grgurević I
    Lijec Vjesn; 2009; 131 Suppl 3():18-23. PubMed ID: 23120847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prediction and monitoring of severe acute pancreatitis].
    Gürlich R; Maruna P; Spicák J
    Cas Lek Cesk; 2006; 145(6):437-41; discussion 442. PubMed ID: 16835994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypsin-based laboratory methods and carboxypeptidase activation peptide in acute pancreatitis.
    Kylänpää-Bäck ML; Kemppainen E; Puolakkainen P
    JOP; 2002 Mar; 3(2):34-48. PubMed ID: 11884765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis.
    Appelros S; Petersson U; Toh S; Johnson C; Borgström A
    Br J Surg; 2001 Feb; 88(2):216-21. PubMed ID: 11167870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the urinary trypsinogen-2 test in the diagnosis of acute pancreatitis.
    Mayumi T; Inui K; Maetani I; Yokoe M; Sakamoto T; Yoshida M; Ko S; Hirata K; Takada T;
    Pancreas; 2012 Aug; 41(6):869-75. PubMed ID: 22481290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early sequential changes in serum markers of acute pancreatitis induced by endoscopic retrograde cholangiopancreatography.
    Lempinen M; Stenman UH; Halttunen J; Puolakkainen P; Haapiainen R; Kemppainen E
    Pancreatology; 2005; 5(2-3):157-64. PubMed ID: 15849486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Search for prognostic markers for acute pancreatitis.
    Windsor JA
    Lancet; 2000 Jun; 355(9219):1924-5. PubMed ID: 10859031
    [No Abstract]   [Full Text] [Related]  

  • 19. ["Trypsinogen activation peptide"--new urine marker for early assessment of the severity of acute pancreatitis?].
    Büchler M; Uhl W
    Z Gastroenterol; 1991 Feb; 29(2):79-81. PubMed ID: 1872003
    [No Abstract]   [Full Text] [Related]  

  • 20. Reliable screening for acute pancreatitis with rapid urine trypsinogen-2 test strip.
    Kylänpää-Bäck M; Kemppainen E; Puolakkainen P; Hedström J; Haapiainen R; Perhoniemi V; Kivilaakso E; Korvuo A; Stenman U
    Br J Surg; 2000 Jan; 87(1):49-52. PubMed ID: 10606910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.